enVVeno Medical (NVNO) vs Sonoma Pharmaceuticals (SNOA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
enVVeno Medical is the larger company by market cap ($6.1 million vs $5.9 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NVNO | SNOA |
|---|---|---|
| Share price | $8.75 | $1.23 |
| Market cap | $6.08M | $5.89M |
| 1-day change | +3.49% | +6.03% |
| EPS (TTM) | $-24.99 | $-1.22 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $30.80 | $4.30 |
| 52-week low | $7.01 | $0.85 |
| Distance from 52-week high | -71.59% | -71.40% |
| Analyst consensus | none | — |
| Avg. price target upside | +242.86% | — |
| Average volume | 23.71K | 107.65K |
| Shares outstanding | 694.83K | 4.79M |
| Employees | 33 | 10 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About enVVeno Medical
NVNO stock →enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. The company's lead product is the VenoValve, a surgical replacement venous valve for the treatment of venous chronic venous insufficiency.
Health Care · Medical/Dental Instruments · 33 employees
About Sonoma Pharmaceuticals
SNOA stock →Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally.
Health Care · Medical/Dental Instruments · 10 employees
NVNO vs SNOA FAQ
Which is bigger, enVVeno Medical or Sonoma Pharmaceuticals?
enVVeno Medical (NVNO) is larger, with a market capitalization of $6.08M compared with $5.89M for Sonoma Pharmaceuticals (SNOA).
Are enVVeno Medical and Sonoma Pharmaceuticals in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.